Northern Trust Corp Virios Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $572 Billion
  • Q1 2024

A detailed history of Northern Trust Corp transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 24,035 shares of VIRI stock, worth $5,528. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,035
Previous 24,035 -0.0%
Holding current value
$5,528
Previous $13,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.35 - $1.94 $2,869 - $15,906
8,199 Added 51.77%
24,035 $33,000
Q2 2022

Aug 12, 2022
BUY
$3.31 - $4.89 $2,379 - $3,515
719 Added 4.76%
15,836 $67,000
Q4 2021

Feb 08, 2022
BUY
$4.07 - $6.12 $61,526 - $92,516
15,117 New
15,117 $77,000

Others Institutions Holding VIRI

# of Institutions
22
Shares Held
681K
Call Options Held
0
Put Options Held
0
View Full List

About Virios Therapeutics, Inc.

VIRI Quotes by TradingView
  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $4.22M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email